read more

first_imgNews | February 02, 2009 Barco Closes Sale of Advanced Visualization to Toshiba Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale Transformations in Molecular Imaging Herald Entry to Novel Applications Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging. read more News | Medical 3-D Printing | August 08, 2019 RSNA and ACR to Collaborate on Landmark Medical 3D Printing Registry The Radiological Society of North America (RSNA) and the American College of Radiology (ACR) will launch a new medical… read more Technology | Virtual and Augmented Reality | June 04, 2019 Ann Arbor Startup Launches Augmented Reality MRI Simulator SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially… read more February 3, 2009 – Barco closed the divestment operation of its Advanced Visualization (AVIS) activities to Toshiba Medical Systems Corp., Tokyo, Japan, in a move by Barco to focus on its medical display systems business. Based in Edinburgh, Scotland, the AVIS group is specialized in 3D clinical software solutions, marketed worldwide under the product names ‘Voxar 3D’ and ‘Voxar 3D Enterprise’. Toshiba now owns all AVIS assets, including its full product portfolio. The decision to sell its AVIS activities arises from the strategic refocusing of Barco’s medical imaging division, concentrating all resources on the development and marketing of medical display systems for diagnostic, surgical and clinical imaging along with custom-built solutions for medical OEMs worldwide. Details of the impact of the operation will be given with the announcement of Barco’s first quarter 2009 financial results on April 22, 2009.For more information: www.barco.com FacebookTwitterLinkedInPrint分享 Related Content Henry Ford Hospital’s ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology. Technology | Virtual and Augmented Reality | June 10, 2019 Medivis SurgicalAR Gets FDA Clearance Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has… read more Image courtesy of Philips Healthcarecenter_img Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor Innovations in Radiotherapy and Radiology at Henry Ford Hospital Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res read more Feature | Advanced Visualization | July 02, 2019 | By Jeff Zagoudis Augmented Reality Versus 3-D Printing for Radiology Three-dimensional (3-D) printing and… read more A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model. Photo courtesy of Nicole Wake, Ph.D. News | Advanced Visualization | July 03, 2019 TeraRecon Unveils iNtuition AI Data Extractor Artificial Intelligence (AI) and advanced visualization company TeraRecon announced its new iNtuition AI Data Extractor… read more Technology | Artificial Intelligence | June 20, 2019 TeraRecon Receives First-of-Kind FDA Determination for Northstar AI Results Explorer Advanced visualization and artificial intelligence (AI) technology provider TeraRecon has successfully completed a U.S… read more Technology | Neuro Imaging | August 07, 2019 Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release… read more Technology | Advanced Visualization | June 13, 2019 Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug… read more last_img

Leave a Reply

Your email address will not be published. Required fields are marked *